{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T13:33:37Z","timestamp":1794576817790,"version":"4.9.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2012,2,22]],"date-time":"2012-02-22T00:00:00Z","timestamp":1329868800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1007\/s00066-011-0060-5","type":"journal-article","created":{"date-parts":[[2012,2,20]],"date-time":"2012-02-20T07:23:53Z","timestamp":1329722633000},"page":"334-339","source":"Crossref","is-referenced-by-count":118,"title":["Integrated boost IMRT with FET-PET-adapted local dose escalation in glioblastomas","Integrated-Boost-IMRT mit FET-PET-adaptierter lokaler Dosiseskalation beim Glioblastom"],"prefix":"10.1007","volume":"188","author":[{"given":"M.D.","family":"Piroth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Pinkawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Holy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Klotz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Schaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Stoffels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Galldiks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.H.","family":"Coenen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.J.","family":"Kaiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.J.","family":"Langen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.J.","family":"Eble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,2,22]]},"reference":[{"key":"60_CR1","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1007\/s00066-010-2101-x","volume":"186","author":"Balducci","year":"2010","unstructured":"Balducci M, Apicella G, Manfrida S et al (2010) Single-arm phase II study of conformal radiation therapy and temozolomide plus fractionated stereotactic conformal boost in high-grade gliomas: final report. Strahlenther Onkol 186:558\u2013564","journal-title":"Strahlenther Onkol"},{"key":"60_CR2","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0167-8140(02)00386-9","volume":"67","author":"Baumert","year":"2003","unstructured":"Baumert BG, Lutterbach J, Bernays R et al (2003) Fractionated stereotactic radiotherapy boost after post-operative radiotherapy in patients with high-grade gliomas. Radiother Oncol 67:183\u2013190","journal-title":"Radiother Oncol"},{"key":"60_CR3","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.ijrobp.2009.06.006","volume":"77","author":"Blonigen","year":"2010","unstructured":"Blonigen BJ, Steinmetz RD, Levin L et al (2010) Irradiated volume as a predictor of brain radionecrosis after linear accelerator stereotactic radiosurgery. Int J Radiat Oncol Biol Phys 77:996\u20131001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"60_CR4","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.ijrobp.2006.02.042","volume":"65","author":"Cardinale","year":"2006","unstructured":"Cardinale R, Won M, Choucair A et al (2006) A phase II trial of accelerated radiotherapy using weekly stereotactic conformal boost for supratentorial glioblastoma multiforme: RTOG 0023. Int J Radiat Oncol Biol Phys 65:1422\u20131428","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"60_CR5","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1200\/JCO.20.6.1635","volume":"20","author":"Chan","year":"2002","unstructured":"Chan JL, Lee SW, Fraass BA et al (2002) Survival and failure patterns of high-grade gliomas after three-dimensional conformal radiotherapy. J Clin Oncol 20:1635\u20131642","journal-title":"J Clin Oncol"},{"key":"60_CR6","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1259\/0007-1285-62-740-679","volume":"62","author":"Fowler","year":"1989","unstructured":"Fowler JF (1989) The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radiol 62:679\u2013694","journal-title":"Br J Radiol"},{"key":"60_CR7","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1007\/s00066-011-2230-x","volume":"187","author":"Gerstein","year":"2011","unstructured":"Gerstein J, Franz K, Steinbach JP et al (2011) Radiochemotherapy with temozolomide for patients with glioblastoma: prognostic factors and long-term outcome of unselected patients from a single institution. Strahlenther Onkol 187:722\u2013728","journal-title":"Strahlenther Onkol"},{"key":"60_CR8","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.ijrobp.2005.01.056","volume":"63","author":"Grosu","year":"2005","unstructured":"Grosu AL, Weber WA, Franz M et al (2005) Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)\/CT\/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy. Int J Radiat Oncol Biol Phys 63:511\u2013519","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"60_CR9","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1007\/s00066-011-2242-6","volume":"187","author":"Guckenberger","year":"2011","unstructured":"Guckenberger M, Mayer M, Buttmann M et al (2011) Prolonged survival when temozolomide is added to accelerated radiotherapy for glioblastoma multiforme. Strahlenther Onkol 187:548\u2013554","journal-title":"Strahlenther Onkol"},{"key":"60_CR10","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0969-8043(02)00225-7","volume":"57","author":"Hamacher","year":"2002","unstructured":"Hamacher K, Coenen HH (2002) Efficient routine production of the 18F-labelled amino acid O-2\u201318F fluoroethyl-L-tyrosine. Appl Radiat Isot 57:853\u2013856","journal-title":"Appl Radiat Isot"},{"key":"60_CR11","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.nucmedbio.2006.01.002","volume":"33","author":"Langen","year":"2006","unstructured":"Langen KJ, Hamacher K, Weckesser M et al (2006) O-(2-[18F]fluoroethyl)-L-tyrosine: uptake mechanisms and clinical applications. Nucl Med Biol 33:287\u2013294","journal-title":"Nucl Med Biol"},{"key":"60_CR12","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0360-3016(98)00266-1","volume":"43","author":"Lee","year":"1999","unstructured":"Lee SW, Fraass BA, Marsh LH et al (1999) Patterns of failure following high-dose 3-D conformal radiotherapy for high-grade astrocytomas: a quantitative dosimetric study. Int J Radiat Oncol Biol Phys 43:79\u201388","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"60_CR13","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1200\/JCO.1990.8.7.1277","volume":"8","author":"Macdonald","year":"1990","unstructured":"Macdonald DR, Cascino TL, Schold SC Jr et al (1990) Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol 8:1277\u20131280","journal-title":"J Clin Oncol"},{"key":"60_CR14","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.ijrobp.2009.09.018","volume":"78","author":"Milano","year":"2010","unstructured":"Milano MT, Okunieff P, Donatello RS et al (2010) Patterns and timing of recurrence after temozolomide-based chemoradiation for glioblastoma. Int J Radiat Oncol Biol Phys 78:1147\u20131155","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"60_CR15","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0167-8140(99)00117-6","volume":"53","author":"Oppitz","year":"1999","unstructured":"Oppitz U, Maessen D, Zunterer H et al (1999) 3D-recurrence-patterns of glioblastomas after CT-planned postoperative irradiation. Radiother Oncol 53:53\u201357","journal-title":"Radiother Oncol"},{"key":"60_CR16","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1093\/brain\/awh399","volume":"128","author":"Pauleit","year":"2005","unstructured":"Pauleit D, Floeth F, Hamacher K et al (2005) O-(2-[18F]fluoroethyl)-L-tyrosine PET combined with MRI improves the diagnostic assessment of cerebral gliomas. Brain 128:678\u2013687","journal-title":"Brain"},{"key":"60_CR17","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1748-717X-4-57","volume":"4","author":"Piroth","year":"2009","unstructured":"Piroth MD, Pinkawa M, Holy R et al (2009) Integrated-boost IMRT or 3-D-CRT using FET-PET based auto-contoured target volume delineation for glioblastoma multiforme \u2013 a dosimetric comparison. Radiat Oncol 4:57","journal-title":"Radiat Oncol"},{"key":"60_CR18","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ijrobp.2010.01.055","volume":"80","author":"Piroth","year":"2011","unstructured":"Piroth MD, Pinkawa M, Holy R et al (2011) Prognostic value of early 18F-fluoroethylthyrosine PET after radiochemotherapy in glioblastoma multiforme. Int J Radiat Oncol Biol Phys 80:176\u2013184","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"60_CR19","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.radonc.2011.03.006","volume":"99","author":"Piroth","year":"2011","unstructured":"Piroth MD, Holy R, Pinkawa M et al (2011) Prognostic impact of postoperative, pre-irradiation 18F-fluoroethyl-L-tyrosine uptake in glioblastoma patients treated with radiochemotherapy. Radiother Oncol 99:218\u2013224","journal-title":"Radiother Oncol"},{"key":"60_CR20","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1007\/s00066-008-1883-6","volume":"184","author":"Rickhey","year":"2008","unstructured":"Rickhey M, Koelbl O, Eilles C et al (2008) A biologically adapted dose-escalation approach, demonstrated for 18F-FET-PET in brain tumors. Strahlenther Onkol 184:536\u2013542","journal-title":"Strahlenther Onkol"},{"key":"60_CR21","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/s00066-010-2014-8","volume":"186","author":"Rickhey","year":"2010","unstructured":"Rickhey M, Moravek Z, Eilles C et al (2010) 18F-FET-PET-based dose painting by numbers with protons. Strahlenther Onkol 186:320\u2013326","journal-title":"Strahlenther Onkol"},{"key":"60_CR22","unstructured":"Roesch P, Netsch T, McNutt T et al (2003) Syntegra \u2013 automated image registration algorithms. Philips White Paper"},{"key":"60_CR23","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3171\/jns.1999.90.1.0072","volume":"90","author":"Shrieve","year":"1999","unstructured":"Shrieve DC, Alexander E III, Black PM et al (1999) Treatment of patients with primary glioblastoma multiforme with standard postoperative radiotherapy and radiosurgical boost: prognostic factors and long-term outcome. J Neurosurg 90:72\u201377","journal-title":"J Neurosurg"},{"key":"60_CR24","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.ijrobp.2004.04.011","volume":"60","author":"Souhami","year":"2004","unstructured":"Souhami L, Seiferheld W, Brachman D et al (2004) Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: report of Radiation Therapy Oncology Group 93-05 protocol. Int J Radiat Oncol Biol Phys 60:853\u2013860","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"60_CR25","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"Stupp","year":"2005","unstructured":"Stupp R, Mason WP, Bent MJ van den et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987\u2013996","journal-title":"N Engl J Med"},{"key":"60_CR26","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1470-2045(09)70025-7","volume":"10","author":"Stupp","year":"2009","unstructured":"Stupp R, Hegi ME, Mason WP et al (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10:459\u2013466","journal-title":"Lancet Oncol"},{"key":"60_CR27","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.ijrobp.2008.05.034","volume":"73","author":"Tsien","year":"2009","unstructured":"Tsien C, Moughan J, Michalski JM et al (2009) Phase I three-dimensional conformal radiation dose escalation study in newly diagnosed glioblastoma: radiation therapy oncology group trial 98-03. Int J Radiat Oncol Biol Phys 73:699\u2013708","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"60_CR28","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/0360-3016(79)90553-4","volume":"5","author":"Walker","year":"1979","unstructured":"Walker MD, Strike TA, Sheline GE (1979) Analysis of dose-effect relationship in the radiotherapy of malignant gliomas. Int J Radiat Oncol Biol Phys 5:1725\u20131731","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"60_CR29","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3171\/jns.1978.49.3.0333","volume":"49","author":"Walker","year":"1978","unstructured":"Walker MD, Alexander E Jr, Hunt WE et al (1978) Evaluation of BCNU and\/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial. J Neurosurg 49:333\u2013343","journal-title":"J Neurosurg"},{"key":"60_CR30","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.radonc.2009.08.043","volume":"93","author":"Weber","year":"2009","unstructured":"Weber DC, Casanova N, Zilli T et al (2009) Recurrence pattern after [(18)F]fluoroethyltyrosine-positron emission tomography-guided radiotherapy for high-grade glioma: a prospective study. Radiother Oncol 93:586\u2013592","journal-title":"Radiother Oncol"},{"key":"60_CR31","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1200\/JCO.2009.26.3541","volume":"28","author":"Wen","year":"2010","unstructured":"Wen PY, Macdonald DR, Reardon DA et al (2010) Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. J Clin Oncol 28:1963\u20131972","journal-title":"J Clin Oncol"},{"key":"60_CR32","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.1200\/JCO.2007.10.7722","volume":"25","author":"Wick","year":"2007","unstructured":"Wick A, Felsberg J, Steinbach JP et al (2007) Efficacy and tolerability of temozolomide in an alternating weekly regimen in patients with recurrent glioma. J Clin Oncol 25:3357\u20133361","journal-title":"J Clin Oncol"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-011-0060-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00066-011-0060-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-011-0060-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T22:31:02Z","timestamp":1558564262000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00066-011-0060-5"}},"subtitle":["Results of a prospective phase II study","Ergebnisse einer prospektiven Phase-II-Studie"],"short-title":[],"issued":{"date-parts":[[2012,2,22]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["60"],"URL":"https:\/\/doi.org\/10.1007\/s00066-011-0060-5","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"value":"0179-7158","type":"print"},{"value":"1439-099X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,22]]}}}